Arno Therapeutics (OTCMKTS:ARNI) Stock Price Down 23.4%

Arno Therapeutics Inc (OTCMKTS:ARNI)’s share price dropped 23.4% on Tuesday . The company traded as low as $0.00 and last traded at $0.00, approximately 2,500 shares were traded during mid-day trading. A decline of 97% from the average daily volume of 73,600 shares. The stock had previously closed at $0.00.

About Arno Therapeutics (OTCMKTS:ARNI)

Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.

See Also: How is a management fee different from a performance fee?

Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.